Friday, April 08, 2022 6:34:38 PM
.
Priced $16.60-$20.50 with the 1:6 R/S.
Honestly. not too confident it will be doing great on debut..
Trend is your friend...look at how debuts have been going for the 1Q22 [https://www.renaissancecapital.com/IPO-Center/News/79727/US-IPO-Weekly-Recap-The-IPO-market-heats-up-in-an-11-IPO-week] I'll be eying for the ole spike & plummet or the plain ole plummet. Unfortunately, most holders will be trapped & can't likely trade out on the R/S. Brokers will take their time to re-org shares and by that time it may be down 50% off debut. Just how these games get played sometimes. R/S really are a $h!tshow. GL
Grouse Hunter
Friday, April 08, 2022 5:06:11 PM
So looks like the offering at today’s pricing is $2.75-$3.42. One would assume investors buying the offering are expecting some upside from there. We should be good in my opinion once we uplift.
Recent APLD News
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
